UNSPSC 51453014: Piperazine hydrochloride

This classification denotes an antihelminthic agent with the molecular formula C4H10N2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 17VU4Z4W88, chemically known as piperazine, dihydrochloride but more generally known as piperazine dihydrochloride, which bears US NIH Compound Identifier 8893. European Medicines Agency schedules Piperazine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14887MIG.

Most nations, for tariff and trade purposes, schedule piperazine hydrochloride under HS 29335990 and SITC 51576. SMILES: C1CNCCN1.CL.CL.

UNSPSC 51453014 Piperazine hydrochloride is a Commodity code that shows limited recent state and local procurement activity directly aligned with its nominal scope. The recent opportunities tagged to this code diverge significantly from the chemical compound itself—they reflect procurement for naloxone and drug deactivation systems, medical and first aid supplies, generic pharmaceuticals and OTC products, and direct-to-manufacturer prescription programs. None of these solicitations target piperazine hydrochloride as a line item or primary deliverable. State and local issuing bodies using pharmaceutical and medical supply codes in this family include county health departments, municipal fire departments, state pharmacy benefit administrators, and cooperative purchasing alliances serving multiple jurisdictions; the recent record shows Seminole County, Florida (community health), the City of Tampa (fire-rescue), the Texas Health and Human Services Commission, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) serving multiple states including Oregon.

Geographic activity appears concentrated in Florida, Texas, and Minnesota, with cooperative purchasing extending across multiple state boundaries through MMCAP. Representative recent opportunities include Seminole County's IFB (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's ITB for 169 line items of medical and first aid supplies for the Fire Department Rescue Division (due March 13, 2026, estimated contract value $700,000, with a 5 percent Small Local Business Enterprise bid discount not to exceed $10,000); and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products across participating states (proposals due March 26, 2026, effective July 1, 2026). The code shows no explicit recent purchasing activity for piperazine hydrochloride itself; vendors serving pharmaceutical and medical supply chains should verify the actual chemical composition or active pharmaceutical ingredient requirements before pursuing opportunities tagged to this commodity code.